News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic to Participate in Scientific and Investor Conferences in March
Immunic to participate in scientific and investor conferences in March including the 34th Annual Meeting of the Society for Virology in Hamburg, Germany, and Leerink Partners Global Healthcare Conference in Miami -
-
-
COMMUNIQUÉ DE PRESSE
Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis
Immunic presents key data on vidofludimus calcium at ACTRIMS Forum 2025, highlighting its potential in multiple sclerosis. Phase 2 CALLIPER trial results expected in April -
-